Cargando…
Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582568/ https://www.ncbi.nlm.nih.gov/pubmed/31217018 http://dx.doi.org/10.1186/s12943-019-1034-y |
| _version_ | 1783428350794006528 |
|---|---|
| author | Yin, Yu Xu, Lingfan Chang, Yan Zeng, Tao Chen, Xufeng Wang, Aifen Groth, Jeff Foo, Wen-Chi Liang, Chaozhao Hu, Hailiang Huang, Jiaoti |
| author_facet | Yin, Yu Xu, Lingfan Chang, Yan Zeng, Tao Chen, Xufeng Wang, Aifen Groth, Jeff Foo, Wen-Chi Liang, Chaozhao Hu, Hailiang Huang, Jiaoti |
| author_sort | Yin, Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6582568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65825682019-06-26 Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway Yin, Yu Xu, Lingfan Chang, Yan Zeng, Tao Chen, Xufeng Wang, Aifen Groth, Jeff Foo, Wen-Chi Liang, Chaozhao Hu, Hailiang Huang, Jiaoti Mol Cancer Correction BioMed Central 2019-06-19 /pmc/articles/PMC6582568/ /pubmed/31217018 http://dx.doi.org/10.1186/s12943-019-1034-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Yin, Yu Xu, Lingfan Chang, Yan Zeng, Tao Chen, Xufeng Wang, Aifen Groth, Jeff Foo, Wen-Chi Liang, Chaozhao Hu, Hailiang Huang, Jiaoti Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title | Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title_full | Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title_fullStr | Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title_full_unstemmed | Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title_short | Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway |
| title_sort | correction to: n-myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating mir-421/ atm pathway |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582568/ https://www.ncbi.nlm.nih.gov/pubmed/31217018 http://dx.doi.org/10.1186/s12943-019-1034-y |
| work_keys_str_mv | AT yinyu correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT xulingfan correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT changyan correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT zengtao correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT chenxufeng correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT wangaifen correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT grothjeff correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT foowenchi correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT liangchaozhao correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT huhailiang correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway AT huangjiaoti correctiontonmycpromotestherapeuticresistancedevelopmentofneuroendocrineprostatecancerbydifferentiallyregulatingmir421atmpathway |